Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Veterinary Digital Pathology Market Size & Share 2026-2035
Report ID: GMI14007
|
Published Date: November 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Veterinary Digital Pathology Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Veterinary Digital Pathology Market Size
The veterinary digital pathology market was valued at USD 487 million in 2025, is expected to reach USD 565 million in 2026, and is projected to expand at a 14.1% CAGR (2026-2035), reaching USD 1.85 billion by 2035.
Veterinary Digital Pathology Market Key Takeaways
Market Leader: IDEXX Laboratories led with over 15.5% market share in 2025.
Leading Players: Top 5 players in this market include IDEXX Laboratories, Leica Biosystems (Danaher), Hamamatsu Photonics, Antech Diagnostics (Mars Petcare), 3DHistech, which collectively held a market share of 56.0% in 2025.
The veterinary digital pathology market is moving from isolated digital-slide deployments toward connected diagnostic workflows that combine scanning, image analysis, remote review, and archival capabilities. Demand is being shaped by rising diagnostic intensity in companion animal care, disease-surveillance requirements in livestock production, and the need for laboratory networks to use specialist pathology capacity more efficiently.
GMI Analyst View
Based on input from industry leaders, the global veterinary digital pathology market generated revenues of USD 426 million in 2024. We view this as evidence that multi-site reference laboratories had begun moving beyond pilot digitization toward operational deployment, as improving scanner throughput and maturing software delivery models lowered the practical barriers to digitizing routine pathology workflows.
Veterinary Digital Pathology Market Trends, Growth Drivers & GMI Forecast Outlook
Veterinary pathology digitization is gaining traction where laboratories can translate faster review, remote specialist access, and automation into measurable workflow improvements. Adoption will remain uneven, however, because scanner financing, storage architecture, and integration requirements vary sharply by institution size, market maturity, and diagnostic caseload.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Animal health receives as little as 0.6% of global health spending despite mounting disease crises, according to WOAH [2]World Organisation for Animal Health. "First Report on World's Animal Health Reveals Changing Spread of Disease Impacting Food Security, Trade and Ecosystems." woah.org. Companion animal demand supports pathology digitization through a recurring clinical-volume mechanism rather than episodic equipment replacement alone. As owners pursue oncology, dermatology, and chronic-disease workups more frequently, laboratories can justify digital workflows that shorten consultation cycles and allow subspecialists to review cases across locations. This favors service models that pair high-throughput scanning with accessible image-review software.
Livestock disease events create a different purchasing rationale. Outbreak investigation, tissue characterization, and regulatory confirmation place a premium on rapid access to pathology expertise, especially when specimens originate far from centralized laboratories. Digital review networks can reduce transport-dependent workflow delays and help veterinary systems direct specialist capacity toward high-consequence disease events.
AI-enabled cellular and tissue-image analysis broadens the addressable market by shifting selected review tasks closer to the point of care. The commercial opportunity is strongest where software can complement, rather than require replacement of, established laboratory workflows and where veterinary-specific training data improves confidence across species and specimen types.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Capital intensity remains the most immediate barrier for small clinics and lower-volume laboratories. The decision is not limited to acquiring a scanner: buyers must also accommodate implementation services, workflow redesign, software licensing, and internal technical support. Flexible commercial models can reduce the initial hurdle, but they do not remove the need to establish a credible utilization and payback case.
Storage requirements become more material as institutions scale from selective digitization to archive-wide workflows. Laboratories must maintain rapid retrieval, reliable high-resolution viewing, and long-term retention while controlling recurring infrastructure costs. The burden is particularly acute when existing information systems were not designed to manage pathology-image archives.
Workforce shortages further compound deployment challenges across digital pathology environments. A limited pool of trained pathology professionals can slow workflow adoption, increase reporting backlogs, and constrain the effective utilization of digital platforms, reinforcing the need for workflow automation, remote consultation capabilities, and robust platform interoperability [7]Walsh E, Orsi NM. "The Current Troubled State of the Global Pathology Workforce." link.springer.com.
GMI Analyst View
We see the forecast as being shaped by two distinct demand models. Companion animal pathology supports recurring, service-led adoption in established clinical networks, while livestock pathology is more closely tied to surveillance mandates and disease-event response. Vendors able to offer both enterprise-grade workflows and cost-adaptive deployment models should be better positioned than suppliers relying on a single hardware-led proposition.
Veterinary Digital Pathology Market Segment Analysis
By Product Type
The veterinary digital pathology market's product mix is anchored by Whole Slide Imaging (WSI) Systems, which held a 46.0% share in 2025 and are projected to generate USD 798 million in revenue by 2035. Scanners remain the foundational investment for laboratories digitizing histology and cytology workflows, with purchasing decisions increasingly centered on throughput, batch handling, image quality, and compatibility with downstream review platforms.
Image Analysis Software generated USD 170 million in 2025 and is projected to grow at a 16.7% CAGR (2026-2035). The segment benefits from laboratories adding AI-assisted workflow capabilities to existing scanner fleets and from cloud-delivered offerings that can extend analytical tools to institutions unable to support broad in-house informatics teams.
Storage & Communication Systems accounted for a 19.1% market share in 2025 and are projected to generate USD 270 million in revenue by 2035. Although these systems are often procured as part of broader workflow packages, they remain essential to multi-site pathology operations by enabling archive access, consultation, and structured movement of image data between laboratories and clinicians.
By Animal Type
Companion Animals generated USD 292 million in 2025 and are projected to reach USD 1.05 billion by 2035. This segment is supported by intensive diagnostic use in oncology, dermatology, and chronic-disease management, where owners and clinicians place a premium on timely specialist review and consistent diagnostic interpretation.
Dogs generated USD 146 million in 2025 and are projected to reach USD 533 million by 2035. Canine oncology and cytology workflows create substantial pathology demand, while expanding use of diagnostic panels and referral networks supports higher specimen volumes and the use of digitally enabled consultation.
Cats held a 20.9% share in 2025 and are projected to grow at a 13.3% CAGR (2026-2035). Feline pathology demand is tied to chronic conditions that require recurring assessment, making reliable access to pathology expertise particularly relevant for clinics managing complex long-term cases.
Livestock is projected to generate USD 700 million by 2035 and is expected to grow at a 16.2% CAGR (2026-2035). Its growth is underpinned by biosecurity, food-safety, and outbreak-management needs, where faster pathology review can influence quarantine decisions, disease-control actions, and herd-level economic outcomes.
Cattle is projected to generate USD 300 million by 2035 and grow at a 15.9% CAGR (2026-2035). Bovine respiratory disease, reproductive pathology, and production-linked health assessment support demand for diagnostic workflows that can connect field samples with centralized pathology expertise.
Swine held an 8.0% share in 2025 and is projected to generate USD 180 million by 2035. Surveillance for high-consequence diseases and intensive production practices make turnaround time and standardized pathology documentation important commercial considerations for pork-sector diagnostic networks.
Poultry is projected to grow at a 17.5% CAGR (2026-2035) and hold a 7.8% market share by 2035. Large commercial flock populations and the operational consequences of infectious disease events favor digital approaches that can support high-throughput review and coordinated surveillance activity.
Wildlife/Exotic Animals held an 8.0% share in 2025 and are projected to grow at a 9.1% CAGR (2026-2035). Demand remains fragmented across zoological institutions, conservation programs, and academic settings, where low sample volumes and species diversity constrain standardization but preserve a need for specialist remote review.
By Application
Diagnosis generated USD 351 million in 2025 and is projected to reach USD 1.30 billion by 2035. Clinical use cases benefit most directly from digital pathology's ability to improve case routing, reduce dependence on physical slide transport, and extend specialist review capacity across hospital and reference-laboratory networks.
Research held a 27.9% share in 2025 and is projected to grow at a 15.0% CAGR (2026-2035). Academic, pharmaceutical, biotechnology, and surveillance users require high-fidelity image archives and reproducible tissue-analysis workflows, supporting adoption of digital-slide infrastructure as a research-enabling platform.
By End Use
Veterinary Hospitals & Clinics generated USD 185 million in 2025 and are projected to grow at a 13.4% CAGR (2026-2035). Adoption at this level is increasingly associated with compact systems, AI-enabled analyzers, and software models that allow practices to access advanced interpretation without building full laboratory-scale infrastructure.
Veterinary Diagnostic Laboratories held a 34.9% share in 2025 and are projected to generate USD 714 million by 2035. Their high caseloads, existing laboratory information systems, and multi-specialist operating models provide a strong foundation for enterprise WSI deployment and remote-review networks.
Academic & Research Institutes held a 22.0% share in 2025 and are projected to grow at a 13.6% CAGR (2026-2035). Veterinary schools and research organizations use digital pathology for instruction, comparative medicine, and collaborative research, although capital acquisition can remain dependent on grant timing and public funding cycles.
GMI Analyst View
We expect the market's strategic value to shift progressively from digitization alone to the quality of the workflow built around digitized images. WSI remains indispensable as the entry point, but differentiation will increasingly depend on species-specific analytical capabilities, integration quality, and the ability to serve both high-volume reference laboratories and distributed clinical users.
Veterinary Digital Pathology Market Regional Analysis
North America Veterinary Digital Pathology Market Analysis
The veterinary digital pathology market in North America generated USD 190 million in 2025 and is projected to reach USD 703 million by 2035. The region combines mature companion animal spending, large reference-laboratory networks, and a deep ecosystem of diagnostic providers, creating favorable conditions for workflow modernization and AI-enabled pathology services.
U.S.
The U.S. generated USD 170 million in 2025 and is projected to reach USD 627 million by 2035. National laboratory networks, specialty-practice density, and a broad companion animal care base support adoption of digitally connected pathology models that can distribute specialist expertise and standardize turnaround expectations.
Canada
Canada held a 4.1% global market share in 2025 and is projected to grow at a 14.2% CAGR (2026-2035). Companion animal diagnostics and livestock biosecurity requirements are supporting laboratory investment, with digital workflows offering a means to connect geographically dispersed clinical and diagnostic resources.
Europe Veterinary Digital Pathology Market Analysis
Europe is projected to generate USD 492 million by 2035 and grow at a 13.5% CAGR (2026-2035). Established academic pathology infrastructure, laboratory consolidation, and livestock-health documentation requirements support the region's transition toward scalable digital pathology networks.
Germany
Germany generated USD 27 million in 2025 and is projected to grow at a 13.1% CAGR (2026-2035). Academic veterinary institutions, reference laboratories, and a strong medical-technology base provide an established platform for WSI adoption across companion animal and production-animal pathology.
U.K.
The U.K. held a 5.5% global market share in 2025 and is projected to generate USD 101 million by 2035. Familiarity with digital pathology infrastructure, high diagnostic engagement among companion animal owners, and established vendor relationships support continued veterinary workflow adoption.
France
France held a 3.9% global market share in 2025 and is projected to generate USD 67 million by 2035. Livestock-health monitoring and veterinary academic activity create parallel demand channels, allowing pathology digitization to serve both clinical care and outbreak-related diagnostic requirements.
Asia Pacific Veterinary Digital Pathology Market Analysis
Asia Pacific generated USD 112 million in 2025 and is projected to grow at a 15.1% CAGR (2026-2035). Growth reflects simultaneous expansion in urban companion animal care and livestock surveillance infrastructure, although deployment models will vary between advanced metropolitan laboratory networks and emerging cloud-connected diagnostic settings.
China
China generated USD 34 million in 2025 and is projected to reach USD 156 million by 2035. Formalization of companion animal care and investment in animal disease surveillance are creating demand across urban clinics, biomedical research institutions, and agricultural diagnostic networks.
Japan
Japan held a 4.9% global market share in 2025 and is projected to generate USD 85 million by 2035. Sophisticated companion animal care, a strong research environment, and the presence of domestic imaging expertise support adoption in academic and commercial laboratories.
India
India held a 2.1% global market share in 2025 and is projected to grow at a 17.2% CAGR (2026-2035). Rising metropolitan companion animal care and extensive livestock-health needs create a broad demand base, while diagnostic modernization programs can accelerate adoption across state and regional laboratory systems.
South Korea
South Korea held a 3.1% global market share in 2025 and is projected to grow at a 14.3% CAGR (2026-2035). Specialty hospitals and a rapidly professionalizing pet-care sector provide an early deployment base from which digitally enabled diagnostic practices can extend beyond major metropolitan centers.
Latin America Veterinary Digital Pathology Market Analysis
Latin America held a 6.0% global market share in 2025 and is projected to generate USD 117 million by 2035. The market is supported by major companion animal and livestock economies, but capital-equipment procurement remains sensitive to macroeconomic conditions and the availability of specialist diagnostic capacity.
Brazil
Brazil generated USD 12 million in 2025 and is projected to reach USD 47 million by 2035. Its large urban pet-care market and export-oriented cattle and poultry industries create complementary sources of demand for pathology workflows that support both clinical diagnostics and food-safety-linked surveillance.
Mexico
Mexico held a 1.4% global market share in 2025 and is projected to grow at a 14.9% CAGR (2026-2035). Growing veterinary care in major cities and cross-border livestock disease surveillance needs create opportunities for laboratories that can provide standardized, digitally supported pathology services.
Middle East & Africa (MEA) Veterinary Digital Pathology Market Analysis
Middle East & Africa (MEA) held a 4.1% global market share in 2025 and is projected to generate USD 80 million by 2035. Demand is concentrated in Gulf markets with government-backed veterinary modernization agendas and in South Africa's comparatively developed referral, academic, and livestock-diagnostic infrastructure.
UAE
The UAE held a 1.0% global market share in 2025 and is projected to grow at a 14.9% CAGR (2026-2035). National biosecurity priorities, food-security planning, and specialist equine care support the case for digitally connected diagnostic capacity. The country's Bio-Security Early Notification System recorded 360 animal disease reports in 2025, including 30 sourced from outside government bodies [2]World Organisation for Animal Health. "First Report on World's Animal Health Reveals Changing Spread of Disease Impacting Food Security, Trade and Ecosystems." woah.org.
Saudi Arabia
Saudi Arabia generated USD 5 million in 2025 and is projected to reach USD 20 million by 2035. Government investment in veterinary infrastructure, companion animal care growth, and surveillance requirements for economically important livestock support a gradual expansion of digital pathology adoption.
GMI Analyst View
We view regional adoption as a set of distinct commercialization environments rather than a uniform global rollout. North America and Europe are increasingly focused on integration and capability upgrades, whereas Asia Pacific is building both hardware and software capacity at once. Earlier-stage regions will require more flexible financing, service support, and deployment architectures to convert policy-led interest into sustained utilization.
Veterinary Digital Pathology Market Share & Competitive Landscape
The veterinary digital pathology market share structure is moderately concentrated, with the five leading participants collectively holding a 56.0% share in 2025. Competition is shaped by scanner capability, image-analysis depth, workflow integration, service reach, and the ability to support both centralized diagnostic laboratories and distributed clinical users.
IDEXX Laboratories held a 15.5% share in 2025. Its integrated position across reference laboratory services, point-of-care diagnostics, and connected data platforms creates meaningful switching costs and supports recurring opportunities to embed digital imaging and AI-enabled analysis in existing customer workflows.
Leica Biosystems (Danaher) held a 13.5% share in 2025. The company's scanner platform portfolio and established laboratory presence position it well with users seeking dependable imaging infrastructure and flexibility to integrate compatible analytical applications.
Hamamatsu Photonics held an 11.0% share in 2025. Its imaging and optics heritage supports its standing in research-oriented pathology environments, while software partnerships can extend its relevance into veterinary diagnostic workflows that require image quality alongside analytical interoperability.
Antech Diagnostics competes through its reference-laboratory network and its ability to deploy digital workflows at scale without requiring every clinic customer to acquire full in-house imaging infrastructure. 3DHistech maintains a differentiated position through its scanner and viewing ecosystem, particularly among academic and research users. Other participants, including Aiforia Technologies, Indica Labs, Proscia, Scopio Labs, Agfa-Gevaert, Sakura Finetek USA, Motic, VCA, and Zoetis, compete through AI software, cloud-native workflow tools, laboratory integration, value-oriented imaging, specialty-hospital demand generation, and diagnostic adjacencies.
Recent Industry Developments
IDEXX Laboratories launched IDEXX Cancer Dx™ in North America in March 2025, expanding its veterinary cancer diagnostic offering with a panel designed for canine lymphoma screening and B versus T cell classification [4]IDEXX Laboratories. "IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals." idexx.com.
IDEXX Laboratories commercially launched the IDEXX inVue Dx™ Cellular Analyzer in December 2024, extending AI-powered, point-of-care cellular imaging into veterinary practice workflows [4]IDEXX Laboratories. "IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals." idexx.com.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →